This is a StreetInsider.com Premium Only Page

MorphoSys AG (MOR) –

Apr 23, 2024 10:14 AM Form 6-K MorphoSys AG For: Apr 23

Apr 22, 2024 10:32 AM Form 6-K MorphoSys AG For: Apr 22

Apr 19, 2024 10:18 AM Form 6-K MorphoSys AG For: Apr 19

Apr 18, 2024 04:32 PM Form SC TO-T/A MorphoSys AG Filed by: NOVARTIS AG

Apr 18, 2024 02:34 PM Form SC 13D MorphoSys AG Filed by: NOVARTIS AG

Apr 18, 2024 10:14 AM Form 6-K MorphoSys AG For: Apr 18

Apr 17, 2024 04:50 PM Form SC 14D9/A MorphoSys AG Filed by: MorphoSys AG

Apr 17, 2024 04:31 PM Form SC TO-T/A MorphoSys AG Filed by: NOVARTIS AG

Apr 16, 2024 05:07 PM Form SC TO-T/A MorphoSys AG Filed by: NOVARTIS AG

Apr 16, 2024 10:13 AM Form 6-K MorphoSys AG For: Apr 16

Apr 15, 2024 03:45 PM Form SC TO-T/A MorphoSys AG Filed by: NOVARTIS AG

Apr 12, 2024 10:55 AM Form 6-K MorphoSys AG For: Apr 12

Apr 11, 2024 11:57 AM Form SC 14D9 MorphoSys AG Filed by: MorphoSys AG

Apr 11, 2024 09:00 AM MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Apr 11, 2024 08:40 AM MorphoSys AG's (MOR) Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Apr 11, 2024 08:39 AM MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis

Apr 11, 2024 06:04 AM Form SC TO-T MorphoSys AG Filed by: NOVARTIS AG

Apr 9, 2024 10:07 AM Form 6-K MorphoSys AG For: Apr 09

Apr 8, 2024 10:20 AM Form 6-K MorphoSys AG For: Apr 08

Apr 4, 2024 10:15 AM Form 6-K MorphoSys AG For: Apr 04

Apr 2, 2024 10:09 AM Form 6-K MorphoSys AG For: Apr 02

Mar 27, 2024 01:16 PM Form 6-K MorphoSys AG For: Mar 27

Mar 26, 2024 11:15 AM Form 6-K MorphoSys AG For: Mar 26

Mar 25, 2024 11:37 AM Form 6-K MorphoSys AG For: Mar 25

Mar 22, 2024 04:46 PM Form SC14D9C MorphoSys AG Filed by: MorphoSys AG

Mar 22, 2024 11:17 AM Form 6-K MorphoSys AG For: Mar 22

Mar 22, 2024 06:48 AM Form 6-K MorphoSys AG For: Mar 22

Mar 22, 2024 02:58 AM MorphoSys AG (MOR) Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis

Mar 22, 2024 02:50 AM MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act

Mar 21, 2024 11:28 AM Form 6-K MorphoSys AG For: Mar 21

Mar 20, 2024 04:14 PM Form 6-K MorphoSys AG For: Dec 31

Mar 20, 2024 11:13 AM Form 6-K MorphoSys AG For: Mar 20

Mar 19, 2024 11:11 AM Form 6-K MorphoSys AG For: Mar 19

Mar 18, 2024 11:24 AM Form 6-K MorphoSys AG For: Mar 18

Mar 15, 2024 04:50 PM Form SC14D9C MorphoSys AG Filed by: MorphoSys AG

Mar 15, 2024 11:20 AM Form 6-K MorphoSys AG For: Mar 15

Mar 14, 2024 04:53 PM Form SC14D9C MorphoSys AG Filed by: MorphoSys AG

Mar 14, 2024 03:16 PM Wells Fargo Downgrades MorphoSys AG (MOR) to Equal Weight

Mar 14, 2024 11:11 AM Form 6-K MorphoSys AG For: Mar 14

Mar 14, 2024 08:28 AM Form 6-K MorphoSys AG For: Dec 31

Mar 13, 2024 05:23 PM Form SC14D9C MorphoSys AG Filed by: MorphoSys AG

Mar 13, 2024 04:13 PM Form 6-K MorphoSys AG For: Dec 31

Mar 13, 2024 04:11 PM Form 6-K MorphoSys AG For: Dec 31

Mar 13, 2024 04:08 PM Form 20-F MorphoSys AG For: Dec 31

Mar 13, 2024 04:03 PM MorphoSys AG (MOR) Tops Q3 EPS by 173c

Mar 13, 2024 04:02 PM MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Mar 12, 2024 11:13 AM Form 6-K MorphoSys AG For: Mar 12

Mar 11, 2024 04:37 PM Form SC 13G MorphoSys AG Filed by: GOLDMAN SACHS GROUP INC

Mar 11, 2024 11:08 AM Form 6-K MorphoSys AG For: Mar 11

Mar 11, 2024 07:06 AM Form 6-K MorphoSys AG For: Mar 07